TSS
ORMP icon

Two Sigma Securities’s Oramed Pharmaceuticals ORMP Stock Holding History

Two Sigma Securities’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,143
Closed -$66K – 2048
2025
Q4 		$66K Buy
+23,143
New +$59.7K 0.01% 1031
2023
Q2 		– Sell
-12,962
Closed -$28.3K – 3187
2023
Q1 		$28.3K Buy
+12,962
New +$41.2K ﹤0.01% 2322
2015
Q2 		– Sell
-11,839
Closed -$75K – 239
2015
Q1 		$75K Buy
+11,839
New +$57.2K 0.08% 144

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Securities's ORMP Position: Q1 2026 in Review

Two Sigma Securities sold out of Oramed Pharmaceuticals (ORMP) in Q1 2026, closing a stake of 23,143 shares — an estimated $66K sold.

Two Sigma Securities first reported a position in ORMP in Q1 2015 and held it in 3 quarters. The position peaked at $75K in Q1 2015. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

  • Two Sigma Securities reported no remaining Oramed Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 23,143 Oramed Pharmaceuticals shares in Q1 2026, an estimated $66K.
  • Two Sigma Securities first reported a position in Oramed Pharmaceuticals in Q1 2015 and held it in 3 quarters.
  • Two Sigma Securities's Oramed Pharmaceuticals position peaked at $75K in Q1 2015.
  • 64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.